These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 10690528)

  • 1. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
    Edler D; Kressner U; Ragnhammar P; Johnston PG; Magnusson I; Glimelius B; Påhlman L; Lindmark G; Blomgren H
    Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer.
    Edler D; Hallström M; Johnston PG; Magnusson I; Ragnhammar P; Blomgren H
    Clin Cancer Res; 2000 Apr; 6(4):1378-84. PubMed ID: 10778966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
    Kamoshida S; Matsuoka H; Ishikawa T; Maeda K; Shimomura R; Inada K; Tsutsumi Y
    Jpn J Clin Oncol; 2004 Oct; 34(10):594-601. PubMed ID: 15591457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of thymidylate synthase levels in the prognosis and the treatment of patients with colorectal cancer.
    Sanguedolce R; Vultaggio G; Sanguedolce F; Modica G; Li Volsi F; Diana G; Guereio G; Bellanca L; Rausa L
    Anticancer Res; 1998; 18(3A):1515-20. PubMed ID: 9673363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and predictive value of the thymidylate synthase expression in patients with non-metastatic colorectal cancer.
    Aguiar S; Lopes A; Soares FA; Rossi BM; Ferreira FO; Nakagawa WT; Carvalho AL; Filho WJ
    Eur J Surg Oncol; 2005 Oct; 31(8):863-8. PubMed ID: 15923105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significance.
    Yamachika T; Nakanishi H; Inada K; Tsukamoto T; Kato T; Fukushima M; Inoue M; Tatematsu M
    Cancer; 1998 Jan; 82(1):70-7. PubMed ID: 9428481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer.
    van Triest B; Pinedo HM; Blaauwgeers JL; van Diest PJ; Schoenmakers PS; Voorn DA; Smid K; Hoekman K; Hoitsma HF; Peters GJ
    Clin Cancer Res; 2000 Mar; 6(3):1063-72. PubMed ID: 10741735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas.
    Diez M; Medrano M; Mugüerza JM; Ramos P; Hernandez P; Villeta R; Martín A; Noguerales F; Ruiz A; Granell J
    Anticancer Res; 2000; 20(5C):3907-12. PubMed ID: 11268475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between expression of thymidylate synthase and colorectal carcinoma].
    Yu ZG; Sun JZ; Zhang Q; Jia HY; Wang JX
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1432-5. PubMed ID: 15500737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site.
    Lenz HJ; Danenberg KD; Leichman CG; Florentine B; Johnston PG; Groshen S; Zhou L; Xiong YP; Danenberg PV; Leichman LP
    Clin Cancer Res; 1998 May; 4(5):1227-34. PubMed ID: 9607581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
    Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
    Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidylate synthase expression as a predictor of the prognosis of curatively resected colon carcinoma in patients registered in an adjuvant immunochemotherapy clinical trial.
    Sakamoto J; Hamashima H; Suzuki H; Ito K; Mai M; Saji S; Fukushima M; Matsushita Y; Nakazato H
    Oncol Rep; 2003; 10(5):1081-90. PubMed ID: 12883662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of thymidylate synthase expression in lymph node metastases of colorectal cancer can improve the prognostic information.
    Ohrling K; Edler D; Hallström M; Ragnhammar P; Blomgren H
    J Clin Oncol; 2005 Aug; 23(24):5628-34. PubMed ID: 16009948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Kornmann M; Schwabe W; Sander S; Kron M; Sträter J; Polat S; Kettner E; Weiser HF; Baumann W; Schramm H; Häusler P; Ott K; Behnke D; Staib L; Beger HG; Link KH
    Clin Cancer Res; 2003 Sep; 9(11):4116-24. PubMed ID: 14519634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
    Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients.
    Mulder WM; Stern PL; Stukart MJ; de Windt E; Butzelaar RM; Meijer S; Adér HJ; Claessen AM; Vermorken JB; Meijer CJ; Wagstaff J; Scheper RJ; Bloemena E
    Clin Cancer Res; 1997 Nov; 3(11):1923-30. PubMed ID: 9815581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M; Drullinsky P; Guillem J; Moore MA
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
    Yamada H; Iinuma H; Watanabe T
    Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.